SBI Securities
NRXP icon

SBI Securities’s NRX Pharmaceuticals NRXP Stock Holding History

SBI Securities’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$58.4K Buy
20,001
+14,900
+292% +$52.9K ﹤0.01% 1110
2026
Q2 		$20.9K Buy
5,101
+2,601
+104% +$8.59K ﹤0.01% 1533
2026
Q1 		$5.32K Hold
2,500
– – ﹤0.01% 2000
2025
Q4 		$6.78K Hold
2,500
– – ﹤0.01% 1898
2025
Q3 		$8.25K Sell
2,500
-892
-26% -$2.55K ﹤0.01% 1855
2025
Q2 		$11.1K Buy
3,392
+1,392
+70% +$3.49K ﹤0.01% 1664
2025
Q1 		$4.1K Buy
+2,000
New +$5.63K ﹤0.01% 1975

Other funds holding NRXP

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
AdvisorShares Investments
AdvisorShares Investments Bethesda, Maryland $796M AUM 17.24% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Prime Capital Investment Advisors
Prime Capital Investment Advisors Overland Park, Kansas $10.2B AUM 17.74% 1-Year Est. Return

SBI Securities's NRXP Position: Q3 2026 in Review

SBI Securities increased its NRX Pharmaceuticals (NRXP) stake by 292% in Q3 2026, buying an estimated $52.9K and bringing the position to 20,001 shares worth $58.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1110.

SBI Securities first reported a position in NRXP in Q1 2025 and has held it in 7 quarters since. 33 funds tracked by Wall St. Rank hold NRXP as of Q3 2026.

  • SBI Securities held 20,001 shares of NRX Pharmaceuticals worth $58.4K as of Q3 2026.
  • SBI Securities bought 14,900 NRX Pharmaceuticals shares in Q3 2026, an estimated $52.9K.
  • NRX Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #1110 holding.
  • SBI Securities first reported a position in NRX Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
  • 33 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.